top of page
The Promising Drug for Tourette Syndrome
MH is a botanical compound, not driven from cannabis. It reverses both vocal and motor tic-like symptoms that are associated with the Tourette Syndrome and thus can become the new class of treatment for Tourette Syndrome based on a novel therapy to the CB2 receptor with selective unique activity. MH reverses ADHD and OCD-like behaviour. Successful pre-clinical studies in mice models for Tourette Syndrome encourage us to further explore this compound. MH is neuroprotective and improves memory functions.
©2020 Fride Pharma
bottom of page